Literature DB >> 16622031

Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis.

Zoltán H Németh1, Balázs Csóka, Jeanette Wilmanski, Dazhong Xu, Qi Lu, Catherine Ledent, Edwin A Deitch, Pál Pacher, Zoltán Spolarics, György Haskó.   

Abstract

The mechanisms governing the impairment of bacterial clearance and immune function in sepsis are not known. Adenosine levels are elevated during tissue hypoxia and damage associated with sepsis. Adenosine has strong immunosuppressive effects, many of which are mediated by A(2A) receptors (A(2A)R) expressed on immune cells. We examined whether A(2A)R are involved in the regulation of immune function in cecal ligation and puncture-induced murine polymicrobial sepsis by genetically or pharmacologically inactivating A(2A)R. A(2A)R knockout (KO) mice were protected from the lethal effect of sepsis and had improved bacterial clearance compared with wild-type animals. cDNA microarray analysis and flow cytometry revealed increased MHC II expression in A(2A)-inactivated mice, suggesting improved Ag presentation as a mechanism of protection. Apoptosis was attenuated in the spleen of A(2A) KO mice indicating preserved lymphocyte function. Levels of the immunosuppressive cytokines IL-10 and IL-6 were markedly lower following A(2A)R blockade. Similar to observations with A(2A)R KO mice, an A(2A)R antagonist increased survival even when administered in a delayed fashion. These studies demonstrate that A(2A)R blockade may be useful in the treatment of infection and sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622031      PMCID: PMC2268092          DOI: 10.4049/jimmunol.176.9.5616

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

Review 1.  Injury, sepsis, and the regulation of Toll-like receptor responses.

Authors:  Thomas J Murphy; Hugh M Paterson; John A Mannick; James A Lederer
Journal:  J Leukoc Biol       Date:  2003-10-13       Impact factor: 4.962

2.  Cutting edge: Physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo.

Authors:  Dmitriy Lukashev; Akio Ohta; Sergey Apasov; Jiang-Fan Chen; Michail Sitkovsky
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

3.  HMG-1 as a late mediator of endotoxin lethality in mice.

Authors:  H Wang; O Bloom; M Zhang; J M Vishnubhakat; M Ombrellino; J Che; A Frazier; H Yang; S Ivanova; L Borovikova; K R Manogue; E Faist; E Abraham; J Andersson; U Andersson; P E Molina; N N Abumrad; A Sama; K J Tracey
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

4.  Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies.

Authors:  M Koshiba; D L Rosin; N Hayashi; J Linden; M V Sitkovsky
Journal:  Mol Pharmacol       Date:  1999-03       Impact factor: 4.436

5.  Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram.

Authors:  G W Sullivan; J Linden; B L Buster; W M Scheld
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

6.  Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.

Authors:  Hong Zhang; David M Conrad; Jared J Butler; Chuanli Zhao; Jonathan Blay; David W Hoskin
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis.

Authors:  Pardis Javadi; Timothy G Buchman; Paul E Stromberg; Kareem D Husain; W Michael Dunne; Cheryl A Woolsey; Isaiah R Turnbull; Richard S Hotchkiss; Irene E Karl; Craig M Coopersmith
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

8.  A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.

Authors:  Gail W Sullivan; Guodong Fang; Joel Linden; W Michael Scheld
Journal:  J Infect Dis       Date:  2004-04-28       Impact factor: 5.226

Review 9.  The dark side of C5a in sepsis.

Authors:  Peter A Ward
Journal:  Nat Rev Immunol       Date:  2004-02       Impact factor: 53.106

Review 10.  Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

Authors:  Michail V Sitkovsky; Dmitriy Lukashev; Sergey Apasov; Hidefumi Kojima; Masahiro Koshiba; Charles Caldwell; Akio Ohta; Manfred Thiel
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  64 in total

1.  Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice.

Authors:  Bryan Belikoff; Stephen Hatfield; Michail Sitkovsky; Daniel G Remick
Journal:  Shock       Date:  2011-04       Impact factor: 3.454

2.  A2B adenosine receptors protect against sepsis-induced mortality by dampening excessive inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Peter Rosenberger; Holger K Eltzschig; Zoltán Spolarics; Pál Pacher; Zsolt Selmeczy; Balázs Koscsó; Leonóra Himer; E Sylvester Vizi; Michael R Blackburn; Edwin A Deitch; György Haskó
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 3.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

4.  Adenosine receptor activation ameliorates type 1 diabetes.

Authors:  Zoltán H Németh; David Bleich; Balázs Csóka; Pál Pacher; Jon G Mabley; Leonóra Himer; E Sylvester Vizi; Edwin A Deitch; Csaba Szabó; Bruce N Cronstein; György Haskó
Journal:  FASEB J       Date:  2007-04-03       Impact factor: 5.191

Review 5.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 6.  Role of nonsynaptic communication in regulating the immune response.

Authors:  Zsolt Selmeczy; E Sylvester Vizi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Neurochem Int       Date:  2007-06-17       Impact factor: 3.921

7.  Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

Authors:  Balázs Csóka; Leonóra Himer; Zsolt Selmeczy; E Sylvester Vizi; Pál Pacher; Catherine Ledent; Edwin A Deitch; Zoltán Spolarics; Zoltán H Németh; György Haskó
Journal:  FASEB J       Date:  2008-07-14       Impact factor: 5.191

8.  Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium.

Authors:  Kevin J Ashton; Melissa E Reichelt; S Jamal Mustafa; Bunyen Teng; Catherine Ledent; Lea M D Delbridge; Polly A Hofmann; R Ray Morrison; John P Headrick
Journal:  Purinergic Signal       Date:  2016-09-30       Impact factor: 3.765

9.  Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Authors:  Mary M Tomayko; Shannon M Anderson; Catherine E Brayton; Saheli Sadanand; Natalie C Steinel; Timothy W Behrens; Mark J Shlomchik
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.